Development of a rapid SARS-CoV-2 neutralisation test by detecting antibodies that block interaction of spike protein receptor-binding domain (RBD) with angiotensin-converting enzyme 2 (ACE2)
暂无分享,去创建一个
C. Richardson | J. Lamont | S. Gildea | M. Dunlop | A. Gallagher | E. Conroy | S. P. Fitzgerald | S. Harkin | E. McCole | S. Savage | R. Mcconnell | L. Mcclafferty | E. Benchikh | C. N. Reid | P. Lowry | J. Curry | S. Fitzgerald